{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T12:29:04Z","timestamp":1790684944459,"version":"4.1.0"},"reference-count":88,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.jaip.2019.06.001","type":"journal-article","created":{"date-parts":[[2019,9,5]],"date-time":"2019-09-05T05:42:47Z","timestamp":1567662167000},"page":"2105-2114","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":117,"title":["Cephalosporin Allergy: Current Understanding and Future Challenges"],"prefix":"10.1016","volume":"7","author":[{"given":"David A.","family":"Khan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleena","family":"Banerji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan A.","family":"Bernstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basar","family":"Bilgicer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly","family":"Blumenthal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Castells","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Ein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2019.06.001_bib1","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1001\/jamainternmed.2016.5651","article-title":"Estimating national trends in inpatient antibiotic use among US hospitals from 2006 to 2012","volume":"176","author":"Baggs","year":"2016","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jaip.2019.06.001_bib2","first-page":"vi25","article-title":"European Surveillance of Antimicrobial Consumption (ESAC): outpatient cephalosporin use in Europe (1997-2009)","volume":"66","author":"Versporten","year":"2011","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.jaip.2019.06.001_bib3","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1111\/all.12881","article-title":"Drug allergies documented in electronic health records of a large healthcare system","volume":"71","author":"Zhou","year":"2016","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2019.06.001_bib4","doi-asserted-by":"crossref","first-page":"778.e1","DOI":"10.1016\/j.amjmed.2009.01.034","article-title":"Self-reported antibiotic allergy incidence and prevalence: age and sex effects","volume":"122","author":"Macy","year":"2009","journal-title":"Am J Med"},{"key":"10.1016\/j.jaip.2019.06.001_bib5","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.jaci.2014.07.062","article-title":"Adverse reactions associated with oral and parenteral use of cephalosporins: a retrospective population-based analysis","volume":"135","author":"Macy","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2019.06.001_bib6","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jaip.2015.07.013","article-title":"Utility of ICD-9-CM codes for identification of allergic drug reactions","volume":"4","author":"Saff","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2019.06.001_bib7","author":"Blumenthal"},{"key":"10.1016\/j.jaip.2019.06.001_bib8","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1111\/all.13440","article-title":"Multiple drug intolerance syndrome and multiple drug allergy syndrome: epidemiology and associations with anxiety and depression","volume":"73","author":"Blumenthal","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2019.06.001_bib9","doi-asserted-by":"crossref","first-page":"4304973","DOI":"10.1155\/2017\/4304973","article-title":"Antibiotic-related adverse drug reactions at a tertiary care hospital in South Korea","volume":"2017","author":"Jung","year":"2017","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.jaip.2019.06.001_bib10","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.jaip.2016.03.008","article-title":"Adverse drug reactions associated with ceftaroline use: a 2-center retrospective cohort","volume":"4","author":"Blumenthal","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2019.06.001_bib11","first-page":"765","article-title":"Rates of cutaneous reactions to drugs","volume":"137","author":"Bigby","year":"2001","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaip.2019.06.001_bib12","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/j.jaip.2018.11.023","article-title":"Drug hypersensitivity reactions documented in electronic health records within a large health system","volume":"7","author":"Wong","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2019.06.001_bib13","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jaip.2014.10.002","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis: a cross-sectional analysis of patients in an integrated allergy repository of a large health care system","volume":"3","author":"Blumenthal","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2019.06.001_bib14","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jaip.2018.06.010","article-title":"Drug-induced anaphylaxis documented in electronic health records","volume":"7","author":"Dhopeshwarkar","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2019.06.001_bib15","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1213\/ANE.0b013e31822d45ac","article-title":"Allergic reactions during anesthesia at a large United States referral center","volume":"113","author":"Gurrieri","year":"2011","journal-title":"Anesth Analg"},{"key":"10.1016\/j.jaip.2019.06.001_bib16","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jaip.2014.11.005","article-title":"Antibiotics are an important identifiable cause of perioperative anaphylaxis in the United States","volume":"3","author":"Gonzalez-Estrada","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2019.06.001_bib17","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.jaip.2016.02.008","article-title":"Antibiotics are the most commonly identified cause of perioperative hypersensitivity reactions","volume":"4","author":"Kuhlen","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2019.06.001_bib18","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.jaip.2018.08.013","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome identified in the electronic health record allergy module","volume":"7","author":"Wolfson","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2019.06.001_bib19","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jaci.2015.05.050","article-title":"Evolving models of the immunopathogenesis of T cell-mediated drug allergy: the role of host, pathogens, and drug response","volume":"136","author":"White","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2019.06.001_bib20","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.iac.2017.07.007","article-title":"Severe delayed drug reactions: role of genetics and viral infections","volume":"37","author":"Pavlos","year":"2017","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaip.2019.06.001_bib21","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1016\/j.jaip.2017.06.017","article-title":"The 3 Cs of antibiotic allergy\u2014classification, cross-reactivity, and collaboration","volume":"5","author":"Trubiano","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2019.06.001_bib22","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.anai.2018.09.459","article-title":"Penicillin minor determinants: history and relevance for current diagnosis","volume":"121","author":"Adkinson","year":"2018","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2019.06.001_bib23","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1084\/jem.114.6.875","article-title":"Studies on the mechanism of the formation of the penicillin antigen, III: the N-(D-alpha-benzylpenicilloyl) group as an antigenic determinant responsible for hypersensitivity to penicillin G","volume":"114","author":"Levine","year":"1961","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jaip.2019.06.001_bib24","first-page":"12","article-title":"Hypersensitivity reactions to beta-lactams: relevance of hapten-protein conjugates","volume":"25","author":"Ariza","year":"2015","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"key":"10.1016\/j.jaip.2019.06.001_bib25","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/jmr.621","article-title":"Synthesis, characterization and immunochemical evaluation of cephalosporin antigenic determinants","volume":"16","author":"Sanchez-Sancho","year":"2003","journal-title":"J\u00a0Mol Recognit"},{"key":"10.1016\/j.jaip.2019.06.001_bib26","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/01.all.0000173788.73401.69","article-title":"Cephalosporin chemical reactivity and its immunological implications","volume":"5","author":"Perez-Inestrosa","year":"2005","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2019.06.001_bib27","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1146\/annurev-pharmtox-010818-021818","article-title":"Applications of immunopharmacogenomics: predicting, preventing, and understanding immune-mediated adverse drug reactions","volume":"59","author":"Karnes","year":"2019","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.jaip.2019.06.001_bib28","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/ng.379","article-title":"HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin","volume":"41","author":"Daly","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaip.2019.06.001_bib29","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/cpt.1375","article-title":"International Drug-Induced Liver Injury Consortium (iDILIC). Drug-induced injury due to flucloxacillin: relevance of multiple HLA alleles","volume":"106","author":"Nicoletti","year":"2019","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jaip.2019.06.001_bib30","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1053\/j.gastro.2011.04.001","article-title":"Susceptibility to amoxicillin-clavulanate-induced liver injury is influenced by multiple HLA class I and II alleles","volume":"141","author":"Lucena","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaip.2019.06.001_bib31","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jaci.2019.01.045","article-title":"HLA-A*32:01 is strongly associated with vancomycin-induced drug reaction with eosinophilia and systemic symptoms","volume":"144","author":"Konvinse","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2019.06.001_bib32","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1021\/acs.chemrestox.6b00253","article-title":"Amoxicillin and clavulanate form chemically and immunologically distinct multiple haptenic structures in patients","volume":"29","author":"Meng","year":"2016","journal-title":"Chem Res Toxicol"},{"key":"10.1016\/j.jaip.2019.06.001_bib33","doi-asserted-by":"crossref","first-page":"423","DOI":"10.4049\/jimmunol.1800237","article-title":"HLA-DQA1, -DQB1, and -DRB1 Alleles sssociated with acute tubulointerstitial nephritis in a Chinese population: a single-center cohort study","volume":"201","author":"Jia","year":"2018","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaip.2019.06.001_bib34","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1128\/AAC.02504-13","article-title":"Tolerability of cefazolin after immune-mediated hypersensitivity reactions to nafcillin in the outpatient setting","volume":"58","author":"Blumenthal","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jaip.2019.06.001_bib35","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0140-6736(18)32218-9","article-title":"Antibiotic allergy","volume":"393","author":"Blumenthal","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2019.06.001_bib36","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1182\/blood-2015-02-628800","article-title":"Genome-wide analysis links NFATC2 with asparaginase hypersensitivity","volume":"126","author":"Fernandez","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2019.06.001_bib37","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1111\/bcp.13294","article-title":"Pharmacogenomics of off-target adverse drug reactions","volume":"83","author":"Garon","year":"2017","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jaip.2019.06.001_bib38","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/all.12821","article-title":"Genetic variants associated with drugs-induced immediate hypersensitivity reactions: a PRISMA-compliant systematic review","volume":"71","author":"Oussalah","year":"2016","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2019.06.001_bib39","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.jaci.2014.07.047","article-title":"HLA-DRA variants predict penicillin allergy in genome-wide fine-mapping genotyping","volume":"135","author":"Gueant","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2019.06.001_bib40","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1046\/j.1440-1754.2003.00267.x","article-title":"Adverse skin and joint reactions associated with oral antibiotics in children: the role of cefaclor in serum sickness-like reactions","volume":"39","author":"King","year":"2003","journal-title":"J\u00a0Paediatr Child Health"},{"key":"10.1016\/j.jaip.2019.06.001_bib41","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S0022-3476(06)80187-3","article-title":"Serum sickness-like reactions to cefaclor: role of hepatic metabolism and individual susceptibility","volume":"125","author":"Kearns","year":"1994","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.jaip.2019.06.001_bib42","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1093\/cid\/ciu126","article-title":"Severe cutaneous adverse reactions related to systemic antibiotics","volume":"58","author":"Lin","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaip.2019.06.001_bib43","first-page":"868","article-title":"GERAP. Hypersensitivity reactions during anesthesia: results from the ninth French survey (2005-2007)","volume":"78","author":"Dong","year":"2012","journal-title":"Minerva Anestesiol"},{"key":"10.1016\/j.jaip.2019.06.001_bib44","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.aller.2013.08.001","article-title":"Perioperative allergic reactions: experience in a Flemish referral centre","volume":"42","author":"Antunes","year":"2014","journal-title":"Allergol Immunopathol (Madr)"},{"key":"10.1016\/j.jaip.2019.06.001_bib45","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.lpm.2016.02.024","article-title":"Epidemiology of perioperative anaphylaxis","volume":"45","author":"Mertes","year":"2016","journal-title":"Presse Med"},{"key":"10.1016\/j.jaip.2019.06.001_bib46","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jaip.2014.11.011","article-title":"Comprehensive allergy evaluation is useful in the subsequent care of patients with drug hypersensitivity reactions during anesthesia","volume":"3","author":"Guyer","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2019.06.001_bib47","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1093\/bja\/aew274","article-title":"Cefalotin as antimicrobial prophylaxis in patients with known intraoperative anaphylaxis to cefazolin","volume":"117","author":"Sadleir","year":"2016","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.jaip.2019.06.001_bib48","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.jaci.2010.06.052","article-title":"IgE-mediated hypersensitivity to cephalosporins: cross-reactivity and tolerability of penicillins, monobactams, and carbapenems","volume":"126","author":"Romano","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2019.06.001_bib49","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.jaci.2014.08.045","article-title":"Patients with positive skin test results to penicillin should not undergo penicillin or amoxicillin challenge","volume":"135","author":"Park","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2019.06.001_bib50","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.jaci.2005.10.032","article-title":"Immediate allergic reactions to cephalosporins: evaluation of cross-reactivity with a panel of penicillins and cephalosporins","volume":"117","author":"Antunez","year":"2006","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2019.06.001_bib51","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1017\/ice.2019.50","article-title":"Outcomes from an inpatient beta-lactam allergy guideline across a large US health system","volume":"40","author":"Blumenthal","year":"2019","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.jaip.2019.06.001_bib52","doi-asserted-by":"crossref","first-page":"S598","DOI":"10.1093\/clinids\/13.Supplement_7.S598","article-title":"Evaluation of the immunologic cross-reactivity of aztreonam in patients with cystic fibrosis who are allergic to penicillin and\/or cephalosporin antibiotics","volume":"13","author":"Moss","year":"1991","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.jaip.2019.06.001_bib53","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.jaci.2015.03.012","article-title":"IgE-mediated hypersensitivity to cephalosporins: cross-reactivity and tolerability of alternative cephalosporins","volume":"136","author":"Romano","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2019.06.001_bib54","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/j.jaip.2016.05.011","article-title":"Cefazolin hypersensitivity: toward optimized diagnosis","volume":"4","author":"Uyttebroek","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2019.06.001_bib55","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1111\/j.1365-2222.2011.03846.x","article-title":"A\u00a0statement on cefazolin immediate hypersensitivity: data from a large database, and focus on the cross-reactivities","volume":"41","author":"Pipet","year":"2011","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2019.06.001_bib56","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1111\/all.13435","article-title":"Incidence of cephalosporin-induced anaphylaxis and clinical efficacy of screening intradermal tests with cephalosporins: a large multicenter retrospective cohort study","volume":"73","author":"Yang","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2019.06.001_bib57","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1111\/j.1365-2222.2005.02317.x","article-title":"Diagnosing immediate reactions to cephalosporins","volume":"35","author":"Romano","year":"2005","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2019.06.001_bib58","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1542\/peds.2007-3178","article-title":"Diagnosing hypersensitivity reactions to cephalosporins in children","volume":"122","author":"Romano","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaip.2019.06.001_bib59","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1111\/all.12182","article-title":"Validation of the cephalosporin intradermal skin test for predicting immediate hypersensitivity: a prospective study with drug challenge","volume":"68","author":"Yoon","year":"2013","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2019.06.001_bib60","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1111\/cea.12455","article-title":"Clinical and diagnostic features of perioperative hypersensitivity to cefuroxime","volume":"45","author":"Christiansen","year":"2015","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2019.06.001_bib61","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0091-6749(03)01783-4","article-title":"Nonirritating intradermal skin test concentrations for commonly prescribed antibiotics","volume":"112","author":"Empedrad","year":"2003","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2019.06.001_bib62","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/j.jaci.2011.12.995","article-title":"Diagnosing nonimmediate reactions to cephalosporins","volume":"129","author":"Romano","year":"2012","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2019.06.001_bib63","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1111\/j.1365-2133.2005.06429.x","article-title":"The usefulness of skin tests to prove drug hypersensitivity","volume":"152","author":"Lammintausta","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2019.06.001_bib64","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/jdv.13796","article-title":"Patch testing\u2014a valuable tool for investigating non-immediate cutaneous adverse drug reactions to antibiotics","volume":"31","author":"Pinho","year":"2017","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaip.2019.06.001_bib65","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/bjd.12125","article-title":"A\u00a0multicentre study to determine the value and safety of drug patch tests for the three main classes of severe cutaneous adverse drug reactions","volume":"168","author":"Barbaud","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2019.06.001_bib66","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/0091-6749(89)90122-X","article-title":"Cross-reactivity between penicillins and cephalosporins: clinical and immunologic studies","volume":"83","author":"Blanca","year":"1989","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2019.06.001_bib67","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0022-1759(92)90311-G","article-title":"Determination of IgE antibodies to the benzyl penicilloyl determinant: a comparison between poly-L-lysine and human serum albumin as carriers","volume":"153","author":"Blanca","year":"1992","journal-title":"J\u00a0Immunol Methods"},{"key":"10.1016\/j.jaip.2019.06.001_bib68","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s12016-013-8367-x","article-title":"Diagnosis and management of immediate hypersensitivity reactions to cephalosporins","volume":"45","author":"Dickson","year":"2013","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.jaip.2019.06.001_bib69","series-title":"Drug allergy testing","article-title":"In vitro and in vivo tests for drug hypersensitivity reactions","author":"Greiwe","year":"2017"},{"key":"10.1016\/j.jaip.2019.06.001_bib70","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.jaip.2016.08.016","article-title":"Diagnosing cefazolin hypersensitivity: lessons from dual-labeling flow cytometry","volume":"4","author":"Uyttebroek","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2019.06.001_bib71","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.anai.2010.08.002","article-title":"Drug allergy: an updated practice parameter","volume":"105","year":"2010","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2019.06.001_bib72","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1111\/all.12390","article-title":"Natural evolution of skin-test sensitivity in patients with IgE-mediated hypersensitivity to cephalosporins","volume":"69","author":"Romano","year":"2014","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2019.06.001_bib73","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1034\/j.1398-9995.2002.23700.x","article-title":"Oral antibiotic adverse reactions after penicillin skin testing: multi-year follow-up","volume":"57","author":"Macy","year":"2002","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2019.06.001_bib74","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1007\/s40521-015-0060-2","article-title":"Rapid desensitization in immediate hypersensitivity reaction to drugs","volume":"2","author":"Giavina-Bianchi","year":"2015","journal-title":"Curr Treat Options Allergy"},{"key":"10.1016\/j.jaip.2019.06.001_bib75","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.jaip.2017.02.014","article-title":"Practical management of antibiotic hypersensitivity in 2017","volume":"5","author":"Macy","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2019.06.001_bib76","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1111\/j.1398-9995.2010.02441.x","article-title":"General considerations on rapid desensitization for drug hypersensitivity\u2014a consensus statement","volume":"65","author":"Cernadas","year":"2010","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2019.06.001_bib77","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jaci.2005.03.037","article-title":"Rapid intravenous cephalosporin desensitization","volume":"116","author":"Win","year":"2005","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2019.06.001_bib78","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.jcf.2009.08.002","article-title":"A\u00a0safe protocol for rapid desensitization in patients with cystic fibrosis and antibiotic hypersensitivity","volume":"8","author":"Legere","year":"2009","journal-title":"J\u00a0Cyst Fibros"},{"key":"10.1016\/j.jaip.2019.06.001_bib79","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1046\/j.1440-1754.1998.00197.x","article-title":"Antibiotic hypersensitivity reactions in cystic fibrosis","volume":"34","author":"Wills","year":"1998","journal-title":"Padiatr Child Health"},{"key":"10.1016\/j.jaip.2019.06.001_bib80","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.jcf.2006.11.001","article-title":"Beta-lactam allergy in adults with cystic fibrosis","volume":"6","author":"Burrows","year":"2007","journal-title":"J\u00a0Cyst Fibros"},{"key":"10.1016\/j.jaip.2019.06.001_bib81","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.anai.2017.09.075","article-title":"Allergic disease in patients with common variable immunodeficiency at a tertiary care referral center","volume":"120","author":"Bjelac","year":"2018","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2019.06.001_bib82","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s10875-016-0353-7","article-title":"Lack of clinical hypersensitivity to penicillin antibiotics in common variable immunodeficiency","volume":"37","author":"Hartman","year":"2017","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.jaip.2019.06.001_bib83","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/ACI.0b013e328355b849","article-title":"Nonimmediate beta-lactam reactions in patients with cystic fibrosis","volume":"12","author":"Whitaker","year":"2012","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2019.06.001_bib84","first-page":"CD006682","article-title":"Duration of intravenous antibiotic therapy in people with cystic fibrosis","volume":"9","author":"Plummer","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jaip.2019.06.001_bib85","first-page":"131","article-title":"Characterization of single and multiple antibiotic allergies in cystic fibrosis patients","author":"Shah","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2019.06.001_bib86","doi-asserted-by":"crossref","first-page":"S608","DOI":"10.1093\/clinids\/13.Supplement_7.S608","article-title":"Retrospective clinical study of hypersensitivity reactions to aztreonam and six other beta-lactam antibiotics in cystic fibrosis patients receiving multiple treatment courses","volume":"13","author":"Koch","year":"1991","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.jaip.2019.06.001_bib87","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.jcf.2011.02.002","article-title":"Rapid desensitization for non-immediate reactions in patients with cystic fibrosis","volume":"10","author":"Whitaker","year":"2011","journal-title":"J\u00a0Cyst Fibros"},{"key":"10.1016\/j.jaip.2019.06.001_bib88","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1016\/j.jaci.2019.01.010","article-title":"Nanoallergen platform for detection of platin drug allergies","volume":"143","author":"Deak","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219819305483?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219819305483?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:19:14Z","timestamp":1761974354000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219819305483"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":88,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S2213219819305483"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2019.06.001","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cephalosporin Allergy: Current Understanding and Future Challenges","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2019.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}